{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:35:16Z","timestamp":1767854116499,"version":"3.49.0"},"reference-count":52,"publisher":"Wiley","issue":"15","license":[{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HE 5825\/2-1"],"award-info":[{"award-number":["HE 5825\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GR 3333\/2-1"],"award-info":[{"award-number":["GR 3333\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1002\/pros.23208","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T10:56:49Z","timestamp":1468580209000},"page":"1364-1374","source":"Crossref","is-referenced-by-count":12,"title":["Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005"],"prefix":"10.1002","volume":"76","author":[{"given":"Martin","family":"Hennenberg","sequence":"first","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Schott","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysenur","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Keller","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Tamalunas","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ciotkowska","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Rutz","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Strittmatter","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Herlemann","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[{"name":"Department of Urology; Ludwig-Maximilians University; Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"issue":"1","key":"10.1002\/pros.23208-BIB0001|pros23208-cit-0001","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"issue":"7","key":"10.1002\/pros.23208-BIB0002|pros23208-cit-0002","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/nau.22467","article-title":"Prostatic alpha1-adrenoceptors: New concepts of function, regulation, and intracellular signaling","volume":"33","author":"Hennenberg","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1002\/pros.23208-BIB0003|pros23208-cit-0003","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.eururo.2013.01.018","article-title":"Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms","volume":"64","author":"Fullhase","year":"2013","journal-title":"Eur Urol"},{"issue":"202","key":"10.1002\/pros.23208-BIB0004|pros23208-cit-0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/978-3-642-16499-6_23","article-title":"Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract","author":"Uckert","year":"2011","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"10.1002\/pros.23208-BIB0005|pros23208-cit-0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00345-005-0017-3","article-title":"Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract","volume":"23","author":"Uckert","year":"2005","journal-title":"World J Urol"},{"issue":"9","key":"10.1002\/pros.23208-BIB0006|pros23208-cit-0006","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1535370213498981","article-title":"Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3\u2032,5\u2032 monophosphate accumulation and adenosine 3\u20325\u2032 triphosphate release from human erythrocytes","volume":"238","author":"Knebel","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1002\/pros.23208-BIB0007|pros23208-cit-0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568016043356273","article-title":"New insights into the intracellular mechanisms by which PGI2 analogues elicit vascular relaxation: Cyclic AMP-independent, Gs-protein mediated-activation of MaxiK channel","volume":"2","author":"Tanaka","year":"2004","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"10.1002\/pros.23208-BIB0008|pros23208-cit-0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-459-3_1","article-title":"NO\/cGMP: The past, the present, and the future","volume":"1020","author":"Russwurm","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1002\/pros.23208-BIB0009|pros23208-cit-0009","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.urology.2012.05.039","article-title":"Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: A functional and biochemical study","volume":"80","author":"Kedia","year":"2012","journal-title":"Urology"},{"issue":"6","key":"10.1002\/pros.23208-BIB0010|pros23208-cit-0010","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.eururo.2006.05.025","article-title":"Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: Present and future","volume":"50","author":"Uckert","year":"2006","journal-title":"Eur Urol"},{"issue":"11","key":"10.1002\/pros.23208-BIB0011|pros23208-cit-0011","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/bph.13099","article-title":"Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864","volume":"172","author":"Wang","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1002\/pros.23208-BIB0012|pros23208-cit-0012","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1046\/j.1464-410x.2000.00573.x","article-title":"Lack of neuropeptide Y receptor detection in human bladder and prostate","volume":"85","author":"Davis","year":"2000","journal-title":"BJU Int"},{"issue":"8","key":"10.1002\/pros.23208-BIB0013|pros23208-cit-0013","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1476-5381.1996.tb15344.x","article-title":"Ouabain-induced increases in resting tone of human hyperplastic prostate following repeated noradrenaline and electrical field stimulation","volume":"117","author":"Guh","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1002\/pros.23208-BIB0014|pros23208-cit-0014","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1021\/jm1002793","article-title":"Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors","volume":"53","author":"Hofgen","year":"2010","journal-title":"J Med Chem"},{"issue":"1","key":"10.1002\/pros.23208-BIB0015|pros23208-cit-0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcp.2012.03.012","article-title":"Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist","volume":"84","author":"Whittle","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/pros.23208-BIB0016|pros23208-cit-0016","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0076-6879(96)68030-6","article-title":"NONOates\u201d (1-substituted diazen-1-ium-1, 2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms","volume":"268","author":"Keefer","year":"1996","journal-title":"Methods Enzymol"},{"issue":"3","key":"10.1002\/pros.23208-BIB0017|pros23208-cit-0017","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.urology.2007.10.051","article-title":"Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue","volume":"71","author":"Uckert","year":"2008","journal-title":"Urology"},{"issue":"5","key":"10.1002\/pros.23208-BIB0018|pros23208-cit-0018","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"issue":"9","key":"10.1002\/pros.23208-BIB0019|pros23208-cit-0019","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/j.1743-6109.2012.02821.x","article-title":"Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck","volume":"9","author":"Angulo","year":"2012","journal-title":"J Sex Med"},{"key":"10.1002\/pros.23208-BIB0020|pros23208-cit-0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2014.09.030","article-title":"Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates","volume":"744","author":"Buono","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1002\/pros.23208-BIB0021|pros23208-cit-0021","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.urology.2008.11.041","article-title":"Effects of phosphodiesterase inhibitors on contraction induced by endothelin-1 of isolated human prostatic tissue","volume":"73","author":"Kedia","year":"2009","journal-title":"Urology"},{"issue":"202","key":"10.1002\/pros.23208-BIB0022|pros23208-cit-0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-642-16499-6_7","article-title":"Anatomy and histology of the lower urinary tract","author":"Pradidarcheep","year":"2011","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"10.1002\/pros.23208-BIB0023|pros23208-cit-0023","first-page":"313","article-title":"The peripheral zone of the prostate is more prone to tumor development than the transitional zone: Is the ETS family the key","volume":"5","author":"Shaikhibrahim","year":"2012","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1002\/pros.23208-BIB0024|pros23208-cit-0024","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11934-007-0072-y","article-title":"Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression","volume":"8","author":"Levitt","year":"2007","journal-title":"Curr Urol Rep"},{"issue":"4","key":"10.1002\/pros.23208-BIB0025|pros23208-cit-0025","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.eururo.2008.11.011","article-title":"Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review","volume":"55","author":"Alcaraz","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1002\/pros.23208-BIB0026|pros23208-cit-0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrurol.2012.192","article-title":"The link between benign prostatic hyperplasia and prostate cancer","volume":"10","author":"Orsted","year":"2013","journal-title":"Nat Rev Urol"},{"issue":"10","key":"10.1002\/pros.23208-BIB0027|pros23208-cit-0027","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1021\/jm500073h","article-title":"Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia","volume":"57","author":"Bartolome-Nebreda","year":"2014","journal-title":"J Med Chem"},{"issue":"12","key":"10.1002\/pros.23208-BIB0028|pros23208-cit-0028","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/onc.2014.94","article-title":"Phosphodiesterase 10A: A novel target for selective inhibition of colon tumor cell growth and beta-catenin-dependent TCF transcriptional activity","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"issue":"3","key":"10.1002\/pros.23208-BIB0029|pros23208-cit-0029","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/jpet.115.230482","article-title":"The phosphodiesterase 10A selective inhibitor TAK-063 improves cognitive functions associated with schizophrenia in rodent models","volume":"356","author":"Shiraishi","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1002\/pros.23208-BIB0030|pros23208-cit-0030","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.18632\/oncotarget.6705","article-title":"Beta-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1002\/pros.23208-BIB0031|pros23208-cit-0031","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneurol.2015.148","article-title":"Neurodegenerative disease: Changes in brain phosphodiesterase 10A levels in neurodegenerative basal ganglia disorders","volume":"11","author":"Wood","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"Pt 10","key":"10.1002\/pros.23208-BIB0032|pros23208-cit-0032","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/brain\/awv219","article-title":"Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease","volume":"138","author":"Niccolini","year":"2015","journal-title":"Brain"},{"issue":"Pt 10","key":"10.1002\/pros.23208-BIB0033|pros23208-cit-0033","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/brain\/awv214","article-title":"Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease","volume":"138","author":"Niccolini","year":"2015","journal-title":"Brain"},{"key":"10.1002\/pros.23208-BIB0034|pros23208-cit-0034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pbb.2015.04.017","article-title":"Pharmacological evaluation of a novel phosphodiesterase 10A inhibitor in models of antipsychotic activity and cognition","volume":"135","author":"Jones","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1002\/pros.23208-BIB0035|pros23208-cit-0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2967\/jnumed.113.131409","article-title":"Phosphodiesterase 10A PET radioligand development program: From pig to human","volume":"55","author":"Plisson","year":"2014","journal-title":"J Nucl Med"},{"issue":"21","key":"10.1002\/pros.23208-BIB0036|pros23208-cit-0036","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1021\/acs.jmedchem.5b01205","article-title":"Synthesis of fluorine-Containing phosphodiesterase 10A (PDE10A) inhibitors and the In vivo evaluation of F-18 labeled PDE10A PET tracers in rodent and nonhuman primate","volume":"58","author":"Li","year":"2015","journal-title":"J Med Chem"},{"issue":"3","key":"10.1002\/pros.23208-BIB0037|pros23208-cit-0037","doi-asserted-by":"crossref","first-page":"e0122197","DOI":"10.1371\/journal.pone.0122197","article-title":"Characterization of binding and inhibitory properties of TAK-063, a novel phosphodiesterase 10A inhibitor","volume":"10","author":"Harada","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1002\/pros.23208-BIB0038|pros23208-cit-0038","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/jpet.114.218552","article-title":"In vivo pharmacological characterization of TAK-063, a potent and selective phosphodiesterase 10A inhibitor with antipsychotic-like activity in rodents","volume":"352","author":"Suzuki","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1002\/pros.23208-BIB0039|pros23208-cit-0039","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/jpet.114.220517","article-title":"AMG 580: A novel small molecule phosphodiesterase 10A (PDE10A) positron emission tomography tracer","volume":"352","author":"Chen","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1002\/pros.23208-BIB0040|pros23208-cit-0040","doi-asserted-by":"crossref","first-page":"F823","DOI":"10.1152\/ajprenal.00011.2014","article-title":"Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate","volume":"307","author":"Kunit","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1002\/pros.23208-BIB0041|pros23208-cit-0041","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","article-title":"The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"63","author":"Giuliano","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1002\/pros.23208-BIB0042|pros23208-cit-0042","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00345-013-1048-9","article-title":"Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide\/cyclic GMP signaling in the human prostate","volume":"31","author":"Uckert","year":"2013","journal-title":"World J Urol"},{"key":"10.1002\/pros.23208-BIB0043|pros23208-cit-0043","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.plefa.2014.11.011","article-title":"Assessing the agonist profiles of the prostacyclin analogues treprostinil and naxaprostene, particularly their DP(1) activity","volume":"95","author":"Syed","year":"2015","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1002\/pros.23208-BIB0044|pros23208-cit-0044","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.bjp.0706841","article-title":"Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations","volume":"149","author":"Jones","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1002\/pros.23208-BIB0045|pros23208-cit-0045","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.juro.2013.03.112","article-title":"Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity","volume":"190","author":"Fullhase","year":"2013","journal-title":"J Urol"},{"issue":"8","key":"10.1002\/pros.23208-BIB0046|pros23208-cit-0046","first-page":"787","article-title":"Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-","volume":"34","author":"Fullhase","year":"2015","journal-title":"Neurourol Urodyn"},{"issue":"26","key":"10.1002\/pros.23208-BIB0047|pros23208-cit-0047","doi-asserted-by":"crossref","first-page":"18438","DOI":"10.1074\/jbc.274.26.18438","article-title":"Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)","volume":"274","author":"Fujishige","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1002\/pros.23208-BIB0048|pros23208-cit-0048","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1432-1327.1999.00963.x","article-title":"Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A","volume":"266","author":"Fujishige","year":"1999","journal-title":"Eur J Biochem"},{"issue":"1","key":"10.1002\/pros.23208-BIB0049|pros23208-cit-0049","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-1119(99)00171-7","article-title":"Isolation and characterization of PDE10A, a novel human 3\u2032, 5\u2032-cyclic nucleotide phosphodiesterase","volume":"234","author":"Loughney","year":"1999","journal-title":"Gene"},{"issue":"12","key":"10.1002\/pros.23208-BIB0050|pros23208-cit-0050","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1073\/pnas.96.12.7071","article-title":"Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A","volume":"96","author":"Soderling","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1002\/pros.23208-BIB0051|pros23208-cit-0051","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1464-410X.2011.10429.x","article-title":"Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: An immunohistochemical study","volume":"109","author":"Nagasaki","year":"2012","journal-title":"BJU Int"},{"issue":"6","key":"10.1002\/pros.23208-BIB0052|pros23208-cit-0052","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/S0022-5347(05)65621-2","article-title":"Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate","volume":"166","author":"Uckert","year":"2001","journal-title":"J Urol"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23208","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pros.23208\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:38:48Z","timestamp":1625459928000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.23208"}},"subtitle":["TC-E 5005 Inhibits Prostate Contraction"],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":52,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23208","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7,15]]}}}